Loading...
Chemical structure of Monlunabant

GC71262

Monlunabant

Also known as N-[(E)-N'-[(E)-C-[(4S)-5-(4-chlorophenyl)-4-phenyl-3,4-dihydropyrazol-2-yl]-N-[4-(trifluoromethyl)phenyl]sulfonylcarbonimidoyl]carbamimidoyl]acetamide

Monlunabant ((S)-MRI-1891) is a solid dispersions compound, as well as a cannabinoid CB1 receptor inhibitor

ChemicalCAS2712480-46-9MW591FormulaC26H22ClF3N6O3S
CAS number
2712480-46-9
Molecular weight
591
Formula
C26H22ClF3N6O3S
Solubility
DMSO ： 100 mg/mL (169·20 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
InChIKey
GYJPQNPVIJXXTA-JOCHJYFZSA-N
Catalogue number
GC71262
Brand
GLPBIO
Computed properties PubChem CID 156861524 · XLogP 5.4 · TPSA 138 Ų · H-bond donors 2
XLogP
5.4
TPSA
138 Ų
H-bond donors
2
H-bond acceptors
8
Rotatable bonds
7
Heavy atoms
40

SMILES CC(=O)N/C(=N/C(=N\S(=O)(=O)C1=CC=C(C=C1)C(F)(F)F)/N2C[C@@H](C(=N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4)/N

Computed descriptors from PubChem (CID 156861524), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.